Application note: Analyte quarterly Vol 1
Posted: 29 June 2018 | Merck KGaA | No comments yet
Your comprehensive guide to multiplex and single protein detection…
We’re here to guide you to choose the best protein detection platform for your needs
What’s better than a well-validated, sensitive, reproducible, robust immunoassay that fits your study requirements? Having a scientific partner offering you a variety of high performance assay platforms. Whether you need rich profiling data from a multiplex panel using Luminex® technology, ultrasensitive detection from an SMC™ assay, robust ELISAs, or maximum throughput from a Gyrolab® workstation, we help you get data you trust.
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
This application note is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
- Biotech leader champions targeted cancer treatments and diversity
- Product hub: Light the path to your next neuroscience discovery with a new ultrasensitive NF-L immunoassay
- A high-throughput macrodomain assay to identify coronavirus drugs
- Building a powerful portfolio of sepsis biomarker signatures for therapeutic clinical trials
- Drug Target Review Assays ebook 2022
Related topics
Antibodies, Assays, Biomarkers, Immuno-oncology, Immunoassays
Related organisations
Merck KGaA
